DYRK1A protein kinase promotes quiescence and senescence through DREAM complex assembly

Larisa Litovchick1, Laurence A Florens, Selene K Swanson

  • 1Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts 02215, USA.

Genes & Development
|April 19, 2011
PubMed

Insights

DYRK1A kinase phosphorylates LIN52, enabling DREAM complex assembly. This process is crucial for cell cycle exit into quiescence and senescence, impacting cell growth regulation.

Area of Science:

  • Cell biology
  • Molecular mechanisms of cell cycle regulation

Background:

  • Cells enter quiescence (G0) or senescence in response to growth signals.
  • The DREAM complex, including MuvB core proteins, represses cell cycle genes during quiescence.
  • The MuvB core switches from BMYB to DREAM during cell cycle entry.

Purpose of the Study:

  • To identify phosphorylation sites regulating the MuvB core switch between BMYB and DREAM.
  • To elucidate the role of DYRK1A in regulating DREAM complex assembly and function.

Main Methods:

  • Mass spectroscopic analysis to identify phosphorylation sites.
  • Inhibition of DYRK1A activity.
  • Point mutation of the LIN52 protein.

Main Results:

  • DYRK1A specifically phosphorylates LIN52 on serine 28.
  • LIN52 phosphorylation is essential for DREAM complex assembly.
  • Inhibition of DYRK1A or LIN52 mutation disrupts DREAM assembly.
  • Disrupted DREAM assembly impairs entry into quiescence and Ras-induced senescence.

Conclusions:

  • DYRK1A-mediated phosphorylation of LIN52 is a key regulatory step for DREAM assembly.
  • DYRK1A plays a critical role in controlling cell cycle exit into quiescence and senescence.

Related Concept Videos

Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Inhibition of CDK Activity02:34

Inhibition of CDK Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
Anaphase Promoting Complex00:50

Anaphase Promoting Complex

The stepwise destruction of specific proteins is necessary for the progression and completion of the cell cycle. Such proteins are ubiquitinated by ubiquitin ligases and then subsequently destroyed by the proteasome. The SCF (Skp1/Cullin/F-box) and the anaphase-promoting complex (APC) are two important ubiquitin ligases involved in cell cycle progression. While SCF is active throughout the cell cycle, APC gets activated during metaphase to anaphase transition. Cdc20 or Cdh1 binds to APC and...